Brii Biosciences Announces Agreement to Acquire VBI’s IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies
Brii Biosciences Limited (“Brii Bio,” “we,” or the “Company”, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, today announced that it has entered into agreements with VBI Vaccines, Inc….
Leading Asia Pacific Biopharmas Power Digital Engagement with Veeva CRM
Veeva Systems (NYSE: VEEV) today announced that 17 of the top 20 biopharmas in Asia Pacific are using Veeva CRM for more effective engagement with healthcare professionals (HCPs). Companies like Boehringer Ingelheim and MSD use Veeva CRM to gain greater…
Revolutionizing Cardiac Care: Aster Medcity’s Stellar Achievement in APAC
Aster Medcity has made an indelible mark in the healthcare industry by being ranked 49th among the top 100 hospitals in the Asia Pacific region for cardiology. This achievement is part of the Best Specialized Hospitals Asia Pacific 2023 survey,…
